Insider Transactions in Q2 2021 at Lexicon Pharmaceuticals, Inc. (LXRX)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 24
2021
|
Philippe Amouyal Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,638
+28.26%
|
-
|
|
Apr 24
2021
|
Sam L Barker Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,638
+13.83%
|
-
|
|
Apr 24
2021
|
Raymond Debbane Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,638
+3.15%
|
-
|
|
Apr 24
2021
|
Robert J Md Lefkowitz Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,638
+28.26%
|
-
|
|
Apr 24
2021
|
Alan S Nies Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,638
+27.73%
|
-
|
|
Apr 24
2021
|
Frank Palantoni Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,638
+28.26%
|
-
|
|
Apr 24
2021
|
Christopher J Sobecki Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,638
+6.57%
|
-
|
|
Apr 24
2021
|
Judith L Swain Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,638
+28.26%
|
-
|